Compound of 3,3,3',3'-tetramethyl-1,1'-spirobiindane-based bisoxazoline ligand, intermediate thereof, preparation method thereof and use thereof
US-2021363135-A1 · Nov 25, 2021 · US
US11220495B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11220495-B2 |
| Application number | US-201716955062-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 29, 2017 |
| Priority date | Dec 22, 2017 |
| Publication date | Jan 11, 2022 |
| Grant date | Jan 11, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided are a compound of 3,3,3′,3′-tetramethyl-1,1′-spirobiindane-based bisoxazoline ligand, an intermediate, a preparation method and uses thereof. The compound of bisoxazoline ligand is a compound having a structure represented by formula I, or an enantiomer, a raceme, or diastereomer thereof. The bisoxazoline ligand can be prepared via a preparation scheme in which the cheap and easily available 6,6′-dihydroxyl-3,3,3′,3′-tetramethyl-1,1′-spirobiindane is used as a starting raw material and the compound represented by formula II serves as the key intermediate through a series of reactions. The new bisoxazoline ligand developed by the present application can be used in catalytic organic reaction, in particular as a chiral bisoxazoline ligand that is widely used in many asymmetric catalytic reactions of metal catalysis, and thus it has economic practicability and industrial application prospect.
Opening claim text (preview).
What is claimed is: 1. A 3,3,3′,3′-tetramethyl-1,1′-spirobiindane-based bisoxazoline ligand, being a compound represented by formula I, or being an enantiomer, or a diastereomer thereof: wherein R 1 and R 6 are each independently selected from the group consisting of hydrogen, C 1 -C 10 alkyl, and aryl; R 2 , R 3 , R 4 , and R 5 are each independently selected from hydrogen, or C 1 -C 10 alkyl; and R 7 is selected from the group consisting of hydrogen, C 1 -C 10 alkyl, C 6 -C 14 aryl, and arylmethylene; R 8 and R 9 are each independently selected from the group consisting of hydrogen, C 1 -C 10 alkyl, and C 6 -C 14 aryl. 2. The 3,3,3′,3′-tetramethyl-1,1′-spirobiindane-based bisoxazoline ligand according to claim 1 , wherein the compound represented by formula I is any one of the following compounds: 3. A method for preparing the compound of formula I according to claim 1 , comprising the following steps of: using the compound of formula II as a starting material, preparing the compound of formula III through a potassium permanganate oxidation reaction, then carrying out an acyl chlorination reaction, condensing with aminoethanol compounds to form amide alcohol, and finally cyclizing to obtain the compound of formula I: wherein, R 1 -R 9 are the same as those defined in claim 1 .
with radicals containing only hydrogen and carbon atoms · CPC title
Crystalline forms, e.g. polymorphs · CPC title
Catalytic cross-coupling, i.e. connection of previously not connected C-atoms or C- and X-atoms without rearrangement · CPC title
linked by a carbon chain containing aromatic rings · CPC title
Iron · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.